Anson Funds Management LP Cor Medix Inc. Transaction History
Anson Funds Management LP
- $542 Million
- Q2 2025
A detailed history of Anson Funds Management LP transactions in Cor Medix Inc. stock. As of the latest transaction made, Anson Funds Management LP holds 725,000 shares of CRMD stock, worth $8.51 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
725,000Holding current value
$8.51 Million% of portfolio
1.65%Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
186Shares Held
33MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$50.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$41.7 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$30.3 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$20.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $484M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...